EP3071555A4 - Hplc analysis of impurities in dianhydrogalactitol - Google Patents

Hplc analysis of impurities in dianhydrogalactitol Download PDF

Info

Publication number
EP3071555A4
EP3071555A4 EP14862051.1A EP14862051A EP3071555A4 EP 3071555 A4 EP3071555 A4 EP 3071555A4 EP 14862051 A EP14862051 A EP 14862051A EP 3071555 A4 EP3071555 A4 EP 3071555A4
Authority
EP
European Patent Office
Prior art keywords
dianhydrogalactitol
impurities
hplc analysis
hplc
analysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14862051.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3071555A1 (en
Inventor
Xiaoyun LU
Mike Tso-Ping Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Del Mar Pharmaceuticals
Original Assignee
Del Mar Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/083,135 external-priority patent/US9029164B2/en
Application filed by Del Mar Pharmaceuticals filed Critical Del Mar Pharmaceuticals
Publication of EP3071555A1 publication Critical patent/EP3071555A1/en
Publication of EP3071555A4 publication Critical patent/EP3071555A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D301/00—Preparation of oxiranes
    • C07D301/02—Synthesis of the oxirane ring
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/74—Optical detectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/84—Preparation of the fraction to be distributed
    • G01N2030/8447—Nebulising, aerosol formation or ionisation
    • G01N2030/8494—Desolvation chambers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8872—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample impurities

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
EP14862051.1A 2013-11-18 2014-11-18 Hplc analysis of impurities in dianhydrogalactitol Withdrawn EP3071555A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/083,135 US9029164B2 (en) 2012-02-27 2013-11-18 Analytical methods for analyzing and determining impurities in dianhydrogalactitol
PCT/US2014/066087 WO2015074025A1 (en) 2013-11-18 2014-11-18 Hplc analysis of impurities in dianhydrogalactitol

Publications (2)

Publication Number Publication Date
EP3071555A1 EP3071555A1 (en) 2016-09-28
EP3071555A4 true EP3071555A4 (en) 2017-05-31

Family

ID=53058168

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14862051.1A Withdrawn EP3071555A4 (en) 2013-11-18 2014-11-18 Hplc analysis of impurities in dianhydrogalactitol

Country Status (10)

Country Link
EP (1) EP3071555A4 (enExample)
JP (1) JP2016538574A (enExample)
KR (1) KR20160108315A (enExample)
CN (1) CN107529337B (enExample)
AU (1) AU2014348232A1 (enExample)
CA (1) CA2931088A1 (enExample)
CL (1) CL2016001197A1 (enExample)
IL (1) IL245713A0 (enExample)
MX (1) MX2016006457A (enExample)
WO (1) WO2015074025A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106397360A (zh) * 2015-07-29 2017-02-15 广西梧州制药（集团）股份有限公司 叔丁醇在去水卫矛醇或其组合物冷冻干燥过程中的应用
MX379918B (es) * 2015-11-25 2025-03-11 Del Mar Pharmaceuticals Bc Ltd Metodos para analisis y resolucion de preparaciones de dianhidrogalactitol y derivados o analogos del mismo.
CN105445407B (zh) * 2015-12-29 2017-04-19 成都普思生物科技股份有限公司 一种山桐子中脂肪酸和维生素e的检测方法
US10927363B2 (en) 2016-04-04 2021-02-23 Mie University DNA sequence and expression vector for alginate lyase
KR102270026B1 (ko) * 2020-01-31 2021-06-28 현대약품 주식회사 (3s)-3-(4-(3-(1,4-다이옥사스파이로[4,5]데스-7-엔-8-일)벤질옥시)페닐)헥스-4-이노익산의 품질 평가 방법
CN114113352A (zh) * 2020-08-28 2022-03-01 深圳波顿香料有限公司 发酵液中内酯型槐糖酯含量的测定方法
US12295919B2 (en) 2022-03-16 2025-05-13 Mie University Methods of treatment and prevention using 4-deoxy-L-erythro-5-hexoseulose uronic acid
CN120741731B (zh) * 2025-09-08 2025-11-14 天津中医药大学 一种基于uplc-qtrap-ms/ms检测扶芳藤或复方扶芳藤合剂中化学成分的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140017798A1 (en) * 2012-02-27 2014-01-16 Del Mar Pharmaceuticals Analytical methods for analyzing and determining impurities in dianhydrogalactitol

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04297868A (ja) * 1991-03-27 1992-10-21 Tonen Corp オリゴ糖の分析方法
JPH09229920A (ja) * 1996-02-26 1997-09-05 Kao Corp グラジェント液体クロマトグラフィー溶離液の処理方法
US6060525A (en) * 1996-03-01 2000-05-09 Dionix Corporation Removal of borate in chromatography
CA2359337C (en) * 1999-01-14 2005-09-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Process for the separation of sugars
US20060148732A1 (en) * 2000-11-17 2006-07-06 Gutterman Jordan U Inhibition of NF-kappaB by triterpene compositions
JP2004294384A (ja) * 2003-03-28 2004-10-21 National Agriculture & Bio-Oriented Research Organization １−デオキシノジリマイシンの測定方法
CA2819769C (en) * 2003-07-18 2016-06-28 Oakwood Laboratories, L.L.C. Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
EP1747457B1 (en) * 2004-05-20 2011-11-30 Novartis AG Analysis of liquid chromatography eluates
JP2008076340A (ja) * 2006-09-25 2008-04-03 Toppan Printing Co Ltd 高感度検出方法およびその検出装置
SI2074120T1 (sl) * 2007-10-25 2010-06-30 Exelixis Inc Tropan spojine
US8772279B2 (en) * 2010-01-29 2014-07-08 Nerviano Medical Sciences S.R.L. 6,7-dihydroimidazo[1,5-a]pyrazin-8(5H)-one derivatives as protein kinase modulators
AU2011292045B2 (en) * 2010-08-18 2016-03-24 Del Mar Pharmaceuticals Method of synthesis of substituted hexitols such as dianhydrogalactitol
CN102008541B (zh) * 2010-10-08 2012-07-04 广西中医学院 无糖型复方扶芳藤制剂中3种主要活性成分的同时检测方法
BE1020835A5 (nl) * 2012-03-20 2014-06-03 Maes Francis N V Werkwijze voor het vervaardigen van een plantenextract, i.h.b. uit desmodium.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140017798A1 (en) * 2012-02-27 2014-01-16 Del Mar Pharmaceuticals Analytical methods for analyzing and determining impurities in dianhydrogalactitol

Also Published As

Publication number Publication date
CL2016001197A1 (es) 2017-06-30
IL245713A0 (en) 2016-08-02
AU2014348232A1 (en) 2016-06-30
KR20160108315A (ko) 2016-09-19
CN107529337A (zh) 2017-12-29
JP2016538574A (ja) 2016-12-08
CN107529337B (zh) 2021-11-16
WO2015074025A1 (en) 2015-05-21
MX2016006457A (es) 2017-01-06
CA2931088A1 (en) 2015-05-21
WO2015074025A9 (en) 2015-12-17
EP3071555A1 (en) 2016-09-28

Similar Documents

Publication Publication Date Title
GB2524222B (en) Activating speech processing
GB2516358B (en) Graphics processing
EP3065875A4 (en) Bioprinter and methods of using same
EP3071209A4 (en) Use of sting agonist as cancer treatment
EP3068240A4 (en) Theacrine-based supplement and method of use thereof
EP2943919A4 (en) Out of stock sensor
EP2994847A4 (en) Analysis of genetic variants
EP2965174A4 (en) INTERACTION OF MULTIPLE PERCEPTIVE DETECTION INPUTS
EP3075001A4 (en) Detectors and methods of using them
PL3004666T3 (pl) Wkręt
GB201317910D0 (en) Speech processing
EP3071555A4 (en) Hplc analysis of impurities in dianhydrogalactitol
EP2992083A4 (en) Analysis of dna
EP2988659A4 (en) Improved methods of cancer detection
EP3059470A4 (en) Ball screw
EP2968445A4 (en) NOVEL CYCLOSPORINE DERIVATIVES AND USES THEREOF
EP3008216A4 (en) Analysis of polynucleotides
EP3049079A4 (en) Solid forms of ceftolozane
EP3060230A4 (en) Conjugates of somatostatin and its analogs
EP3004289A4 (en) Treatment of coal
HUE038488T2 (hu) Szerves szennyezõdések detektálása
EP3060689A4 (en) Leaching of minerals
EP3018385A4 (en) Ball screw
EP3052656A4 (en) Methods of determining polymorphisms
EP3008213A4 (en) Detection of protein to protein interactions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160531

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170504

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 30/88 20060101ALI20170426BHEP

Ipc: C07D 301/02 20060101AFI20170426BHEP

Ipc: C07D 303/14 20060101ALI20170426BHEP

Ipc: G01N 30/84 20060101ALN20170426BHEP

Ipc: G01N 30/74 20060101ALI20170426BHEP

Ipc: G01N 30/22 20060101ALI20170426BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DEL MAR PHARMACEUTICALS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190601